Rare diseases
Investigational molecules
Locations
Study on the Effects of Ianalumab with Standard Therapy for Patients with Active Lupus Nephritis
CzechiaStudy on the Effects of Selgantolimod and NUC Discontinuation in Patients with Chronic Hepatitis B
FranceStudy Comparing DTG/3TC and BIC/FTC/TAF for Maintaining HIV Control in Adults
SpainStudy on the Effects of Ianalumab in Adults with Rheumatoid Arthritis, Systemic Lupus Erythematosus, or Sjögren’s Disease
CzechiaStudy on Switching to Emtricitabine, Tenofovir Alafenamide, and Bictegravir for HIV-1 Patients Unable or Unwilling to Continue Injectable Therapy
FranceStudy on the Effectiveness and Safety of JNJ-73763989 and Tenofovir Alafenamide in Patients with Hepatitis B and D Co-infection
FranceStudy on the Effects of Doravirine on Liver Health in People Living with HIV with Liver Steatosis or Fibrosis
SpainStudy on the Effects of RBD1016 and Tenofovir Alafenamide for Patients with Chronic Hepatitis D Infection
SwedenStudy on HIV-1 Treatment for Patients New to Therapy: Comparing Doravirine/Islatravir with a Drug Combination
FranceStudy on Switching to Islatravir and MK-8507 for Adults with HIV-1 Who Are Virologically Suppressed on a Drug Combination
FranceStudy on Switching from Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV Patients with Good Control and Neuropsychiatric Concerns
SpainStudy on Ianalumab for Patients with Systemic Lupus Erythematosus
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
